Prevention of Barrett’s Esophagus (BE) and Esophageal Adenocarcinoma (EAC) in the Levrat rat model of EAC by treatment with the smoothened (SMO) inhibitor
Prevention of Barrettâs Esophagus (BE) and Esophageal Adenocarcinoma (EAC) in the Levrat rat model of EAC by treatment with the smoothened (SMO) inhibitor
2nd World Congress on Cancer Science & Therapy
September 10-12, 2012 Hilton San Antonio Airport, USA